Deep Knowledge Group Announces Launch of New Strategic Project: Quant Biomarkers Company in Basel, S
The unified data-driven Biomarkers Platform specializes in the aggregation and synthesis of validated biomarker technologies for the development of sophisticated analytical products for Precision Medicine, Practical Human Longevity, InsurTech and InvestTechBASEL, Switzerland--(BUSINESS WIRE)--Deep Knowledge Group an...
United Kingdom Sanja Baumann Tomovska Sanja Tomovska Knowledge Group Longevity International Association Precision Health
Source: pharmiweb.com